Australian Medication Safety Services
  • Home
  • Advisory Services & Analysis
  • Expert Clinical Guidance
  • Education
  • Medical Writing
  • Research Design & Supervision
  • Medicolegal Consulting
  • Comments
Select Page

Dual antiplatelets after percutaneous coronary intervention – longer treatment does not yield better outcomes

Mar 28, 2019

P2Y12 Inhibitor Monotherapy vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention – SMART-CHOICE. Presented at the American College of Cardiology Annual Scientific Session (ACC 2019), New Orleans March 2019. This research...

Target HbA1c of 6.5 – 7.4% for older people treated with insulin for type II diabetes

Mar 27, 2019

Researchers have studied the relationship between HbA1c concentrations, cardiovascular morbidity and all-cause mortality among older insulin-treated patients with type 2 diabetes (T2D), using data from 4589 adults >65 years on insulin treatment, sourced from 532 UK...

New international guidelines for management of post-menopausal osteoporosis

Mar 27, 2019

New international guidance synthesized using evidence from clinical trials and clinical experience with pharmacological has recently been published to guide management of postmenopausal osteoporosis. Four management principles were addressed: risk of future fractures...

In the absence of active bleeding, vitamin K may not add in management of moderate over-warfarinization

Mar 26, 2019

People over-anticoagulated with warfarin who have an INR between 4.5 and 10 are at increased risk of bleeding, but is the administration of vitamin K an effective and safe strategy to adopt if there is no active bleeding? A systematic review of relevant randomized...

Edible cannabis products over-represented amongst ED department presentations

Mar 26, 2019

Colorado was one of the front-runner jurisdictions for legalized recreational cannabis use in the USA. In a study supported by the Colorado Department of Public Health and Environment, researchers have examined adult emergency department (ED) visits related to edible...
« Older Entries

Recent Posts

  • Muscle symptoms don’t necessarily preclude further statin treatment
  • PPIs associated with increased risk of asthma in children
  • Anticoagulation and Covid19 infection
  • Semaglutide for weight loss
  • Involving pharmacists as prescribers improves prescription accuracy in hospitals

Archives

  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018

Copyright © 2025 Australian Medication Safety Services | PO Box 179, Glen Osmond, South Australia 5064 | Email: admin@medsafetyaustralia.com.au

Website Design